IIIV
i3 Verticals, Inc.
IIIV's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over IIIV overall, supported by stronger valuation and stronger modeled upside.
IIIV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Under pressure |
IIIV's cash flow is currently strong, and its revenue and profitability are stable, but its balance sheet is under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
IIIV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.6x | $2.35 | -87% |
| Forward | 15x | $18.64 | — |
| Fair | 28x | $11.67 | -37% |
| Expensive | 40x | $16.63 | -11% |
| Current | 44x | $18.64 | — |
Historical ranges are pointers, not guarantees.
IIIV's PE is in its expensive range at 44x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its fair range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over IIIV in the historical PE scenario, which offers more potential upside but is not a forecast.
IIIV Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect IIIV's earnings to grow and its profitability to improve, with its revenue holding steady.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
IIIV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.22 | +191% |
| Q2 2026 | $0.42 | -92% |
| Q1 2026 | $0.74 | -83% |
| Q4 2025 | $0.66 | -85% |
| Q3 2025 | $0.72 | -84% |
| Q2 2025 | $5.22 | +$5.26 |
| Q1 2025 | $4.40 | +7233% |
| Q4 2024 | $4.49 | +$4.51 |
| Q3 2024 | $4.45 | +$4.52 |
IIIV's earnings per share have fallen from their peak: $0.42 over the past year, against $5.22 in mid-2025.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over IIIV on earnings, with more consistent year-over-year improvement.
IIIV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $53.1M | +2.2% |
| Q1 2026 | $57.5M | -8.8% |
| Q4 2025 | $52.7M | -15% |
| Q3 2025 | $54.9M | -9.8% |
| Q2 2025 | $51.9M | -7.4% |
| Q1 2025 | $63.1M | -33% |
| Q4 2024 | $61.7M | -33% |
| Q3 2024 | $60.9M | -37% |
IIIV's revenue has slid since its 2019 peak: $53M last quarter, up 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1.7% | +7.6 points |
| Q1 2026 | 6.5% | +0.2 points |
| Q4 2025 | 3% | -1.3 points |
| Q3 2025 | 2.7% | -3.1 points |
| Q2 2025 | -9.3% | -8.1 points |
| Q1 2025 | 6.3% | -3.7 points |
| Q4 2024 | 4.4% | -4.9 points |
| Q3 2024 | 5.8% | -3.3 points |
IIIV's operating margin was −1.7% last quarter, up 7.6 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over IIIV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over IIIV on profitability, with a higher operating margin.
IIIV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $13M | +90% |
| Q1 2026 | $9.6M | +$37.2M |
| Q4 2025 | $13.8M | +25% |
| Q3 2025 | $13.5M | +14% |
| Q2 2025 | $6.8M | -5.7% |
| Q1 2025 | -$27.6M | -345% |
| Q4 2024 | $11M | -11% |
| Q3 2024 | $11.8M | +213% |
IIIV generated $50M in free cash flow over the past year, more than ten times what it generated the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over IIIV on cash flow, with more consistent year-over-year improvement.
IIIV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -36% | -11M shares |
| 1 year | -42% | -14.4M shares |
| 3 years | -43% | -14.7M shares |
| 5 years | +2.2% | +415K shares |
| Available history | +86% | +9.1M shares |
IIIV has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $48.1M |
| Q1 2026 | $50.9M |
| Q4 2025 | $37.9M |
| Q3 2025 | — |
| Q2 2025 | $26.1M |
| Q1 2025 | $308,000 |
| Q4 2024 | $11.2M |
| Q3 2024 | $29,000 |
IIIV spent $137M buying back its own shares over the past year, about four times what it spent the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
IIIV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | -1.2x | Net Cash |
| Q3 2025 | -2.0x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -1.2x | Net Cash |
| Q3 2024 | -0.8x | Net Cash |
IIIV's net debt is about 3.2 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over IIIV on leverage, with a lower net debt burden relative to earnings.
IIIV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 63.0 | Neutral |
IIIV's weekly RSI is 51 (neutral) and its Stochastic is 63 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
IIIV PE vs Technology Sector
| Metric | IIIV | Sector median | Relative |
|---|---|---|---|
| PE | 44x | 28x | 59% above |
| PE % | 88 | 35 | 53 pts above |
IIIV is trading at 44x earnings, a 59% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over IIIV on valuation relative to its sector.
IIIV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.8 | 11% above |
| 20 week MA | $17.6 | 5.7% above |
| 50 week MA | $20.6 | 9.3% below |
| 100 week MA | $23.9 | 22% below |
| 200 week MA | $23.1 | 19% below |
IIIV has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
IIIV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.3 | $32.9 | +16% |
| 2021 | $32.9 | $23.2 | -29% |
| 2022 | $23.2 | $24.0 | +3.1% |
| 2023 | $24.0 | $21.2 | -12% |
| 2024 | $21.2 | $23.9 | +13% |
| 2025 | $23.9 | $26.2 | +9.4% |
| 2026 YTD | $26.2 | $18.6 | -29% |
IIIV has finished higher in four of the last six years. It's down 29% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over IIIV on returns for 2026, with the stronger performance.